Corrigendum: Diplatin, a Novel and Low-Toxicity Anti-Lung Cancer Platinum Complex, Activation of Cell Death in Tumors via a ROS/JNK/p53-Dependent Pathway, and a Low Rate of Acquired Treatment Resistance

Affiliations

• ¹ Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
• ² Zhejiang Respiratory Drugs Research Laboratory of Food and Drug Administration of China, Zhejiang University School of Medicine, Hangzhou, China.
• ³ Breath Smooth Biotech Hangzhou Co., LTD, Hangzhou, China.
• ⁴ Beijing Shuobai Pharmaceutical Co., LTD, Beijing, China.
• ⁵ Joinn Laboratories, BAD, Beijing, China.
• ⁶ Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.